@article{27fb4200d96f4be8921d7f10206162b0,
title = "Author Correction: Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis (Nature Medicine, (2021), 27, 5, (802-805), 10.1038/s41591-021-01324-7)",
abstract = "In the version of this Letter initially published, the Acknowledgements section omitted the following text: “T.K.C. is supported in part by the Dana–Farber/Harvard Cancer Center Kidney Specialized Program of Research Excellence and program, the Kohlberg Chair at Harvard Medical School, the Trust Family, Michael Brigham, and Loker Pinard Funds for Kidney Cancer Research at Dana–Farber Cancer Institute, and by various grants from the National Cancer Institute, Department of Defense, and foundations. Authors were also supported by NCI grants P50 CA101942 and U01 CA236489 to D.F.M. and T.K.C.” This addition has now been included in the Acknowledgements. The original Letter has been corrected in the online version of the paper.",
author = "Choueiri, {Toni K.} and Bauer, {Todd M.} and Papadopoulos, {Kyriakos P.} and Plimack, {Elizabeth R.} and Merchan, {Jaime R.} and McDermott, {David F.} and Michaelson, {M. Dror} and Appleman, {Leonard J.} and Sanjay Thamake and Perini, {Rodolfo F.} and Zojwalla, {Naseem J.} and Eric Jonasch",
note = "Funding Information: In the version of this Letter initially published, the Acknowledgements section omitted the following text: “T.K.C. is supported in part by the Dana–Farber/Harvard Cancer Center Kidney Specialized Program of Research Excellence and program, the Kohlberg Chair at Harvard Medical School, the Trust Family, Michael Brigham, and Loker Pinard Funds for Kidney Cancer Research at Dana–Farber Cancer Institute, and by various grants from the National Cancer Institute, Department of Defense, and foundations. Authors were also supported by NCI grants P50 CA101942 and U01 CA236489 to D.F.M. and T.K.C.” This addition has now been included in the Acknowledgements. Publisher Copyright: {\textcopyright} The Author(s), under exclusive licence to Springer Nature America, Inc. 2021.",
year = "2021",
month = oct,
doi = "10.1038/s41591-021-01516-1",
language = "English (US)",
volume = "27",
pages = "1849",
journal = "Nature medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "10",
}